Zerbaxa - supply shortage

Resolved

ceftolozane

tazobactam

Shortage information

The shortage affecting Zerbaxa has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Zerbaxa
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  • ceftolozane
  • tazobactam
• Therapeutic area (MESH):
  Bacterial Infections
• Pharmaceutical forms affected:
  Concentrate for solution for infusion
• Strengths affected:
  • 1 g
  • 0.5 g
• Availability of alternatives:
  Yes

Key dates

• First published:
  22/12/2020
• Last updated:
  14/04/2023